These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33070132)

  • 1. Influence of Simvastatin as Augmentative Therapy in the Treatment of Generalized Anxiety Disorder: A Pilot Randomized, Placebo-Controlled Study.
    Mirzaei E; Mirjalili M; Jahangard L; Haghighi M; Yasrebifar F; Mohammadi Y; Larki-Harchagani A; Mehrpooya M
    Neuropsychobiology; 2021; 80(3):242-252. PubMed ID: 33070132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does anxiety moderate the effectiveness of mirtazapine in patients with treatment-resistant depression? A secondary analysis of the MIR trial.
    Rifkin-Zybutz R; MacNeill S; Davies SJ; Dickens C; Campbell J; Anderson IM; Chew-Graham CA; Peters TJ; Lewis G; Wiles N; Kessler D
    J Psychopharmacol; 2020 Dec; 34(12):1342-1349. PubMed ID: 33143538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
    Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
    Ann Clin Psychiatry; 2014 Feb; 26(1):3-18. PubMed ID: 24660224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
    Khan A; Atkinson S; Mezhebovsky I; She F; Leathers T; Pathak S
    Ann Clin Psychiatry; 2013 Nov; 25(4):E7-22. PubMed ID: 24199224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Efficacy of
    Fuladi S; Emami SA; Mohammadpour AH; Karimani A; Manteghi AA; Sahebkar A
    Curr Rev Clin Exp Pharmacol; 2021; 16(2):191-196. PubMed ID: 32282308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentative quetiapine in partial/nonresponders with generalized anxiety disorder: a randomized, placebo-controlled study.
    Altamura AC; Serati M; Buoli M; Dell'Osso B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):201-5. PubMed ID: 21403524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.
    Pollack MH; Zaninelli R; Goddard A; McCafferty JP; Bellew KM; Burnham DB; Iyengar MK
    J Clin Psychiatry; 2001 May; 62(5):350-7. PubMed ID: 11411817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
    McIntyre A; Gendron A; McIntyre A
    Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
    Pollack MH; Simon NM; Zalta AK; Worthington JJ; Hoge EA; Mick E; Kinrys G; Oppenheimer J
    Biol Psychiatry; 2006 Feb; 59(3):211-5. PubMed ID: 16139813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study.
    Brawman-Mintzer O; Knapp RG; Nietert PJ
    J Clin Psychiatry; 2005 Oct; 66(10):1321-5. PubMed ID: 16259547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
    Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T
    J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
    Montgomery SA; Tobias K; Zornberg GL; Kasper S; Pande AC
    J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
    Durgam S; Gommoll C; Forero G; Nunez R; Tang X; Mathews M; Sheehan DV
    J Clin Psychiatry; 2016 Dec; 77(12):1687-1694. PubMed ID: 27232052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
    Meoni P; Salinas E; Brault Y; Hackett D
    J Clin Psychiatry; 2001 Nov; 62(11):888-93. PubMed ID: 11775049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
    Davidson JR; Bose A; Korotzer A; Zheng H
    Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.